期刊文献+

罗格列酮对高血压大鼠主动脉壁保护作用的形态学研究 被引量:4

Morphological study on protective effect of rosiglitazone on aorta wall of spontaneous hypertension rats
下载PDF
导出
摘要 目的探讨罗格列酮对自发性高血压大鼠(SHR)血管壁的保护作用。方法SHR大鼠24只,分成SHR组及罗格列酮组,罗格列酮组饮水中加入罗格列酮,用光镜和电镜的方法,评价两组大鼠主动脉内皮细胞、平滑肌细胞等形态学特点。结果SHR大鼠主动脉壁内膜层、平滑肌层均存在一些形态学方面的异常,经罗格列酮治疗后这些形态学异常得到抑制或改善。结论从形态学角度证实罗格列酮具有一定的血管保护作用。 Objective To explore the protective effects of rosiglitazone on the vascular system of spontaneous hypertensive rat (SHR). Methods 24 SHR rats were divided into observation group (rosiglitazone put into drinking water) and control group. The morphological features of endothelial cells and smooth muscle cells in aorta were evaluated by light and electro-microscope. Results Some histopathological changes appeared in the endomembrane and smooth muscle layer of aorta wall of SHR rats were inhibited or improved with rosiglitazone.Conclusions It approved that rosiglitazone could have a certain vascular protective function from the point of view of morphology.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2005年第4期416-418,共3页 Chinese Journal of Gerontology
基金 吉林省科技厅中标课题(编号:20010517)
关键词 罗格列酮 自发性高血压大鼠 主动脉壁 形态学 Rosiglitazone Spontaneous hypertension rat Aorta wall Morphology
  • 相关文献

参考文献9

  • 1孔俭,孙捷,汲宏磊.罗格列酮对自发性高血压大鼠的降压作用[J].高血压杂志,2003,11(5):454-456. 被引量:39
  • 2Reaven GM. Banting Lecture 1988.Role of insulin resistance in human disease[J]. Diabetes,1988;37(12):1595-607.
  • 3Diep ON, Cohn JS .Schiffrin EL. Structure,endothelial function ,cell growth and inflammation in blood vessels of angiotensin II -induced rats :role of peroxisome proliferator-activated receptor-gamma [J].Circulation,2002;105(19):2296-302.
  • 4WalkerAB. Chattington PD,William SG ,et al . The thiazolidinedione rosiglitazone(BRL -L9653) lowers the blood pressure and protects against impairment of endothelial function in Zuker fatty rats[J]. Diabetes,1999;48(7):1448-53.
  • 5Sidhu JS, Cowan D , Kaski JC,et al . The effects of rosiglitazone. A peroxisome proliferators-activated receptor -gamma agonist,on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non -diabetic coronary artery disease patients [J]. J Am Coll Cardiol,2003;42(10):1757-63.
  • 6Wang CH ,Stanford WL ,Verma S, et al .Facilitate angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in giltazone pleiotropy [J].Circulation,2004;109(11):1392-400.
  • 7Dilley RJ ,Jennings GL ,Law RE ,et al . Inhibitory activity of clinical thiazolidinedione peroxisome proliferators activating receptor-gamma ligands toward internal mammary artery, radial artery, and saphenous vein smooth muscle cell proliferation [J].Circulation,2003;107(20):2548-50.
  • 8Weber AA, Seul C, Sachinidis A ,et al . Troglitazone and rosiglitazone inhibit the low density lipoprotein-induced vascular smooth muscle cell growth[J]. Exp Clin Endocrinol Diabetes,2001;109(4):203-9.
  • 9Law RE, Goetze S, Xipe T, et al . Ppar-gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells [J].J Cardiovasc Pharmacol,1999;33(5):798-806.

二级参考文献6

  • 1Reaven GM. Insulin resistance, hyperinsulinemia and hypertriglyceridemia in etiology and clinical course of hypertension[J ].Am J Med, 1991,90:7- 12.
  • 2Sanjay Bhanot. Vanadyl sulfate prevents fructose induced hypetinsu linemia and hypertension in rats[J]. Hypertension, 1994, Vol 23, No3.
  • 3Sanjay B. Insulin and hypertension: a causal relationship[J]? Cardiovascuolar Research, 31 ( 1996)212 - 221.
  • 4Yokota. Insulin resistance rather than hyperinsulinemia more closely associated with essential hypertension [ J ]. Clin Exp hypertens, 1995,17:523 - 36.
  • 5Raji A. Rosiglitazone improve insuline-sensitive and lowers blood pressure in hypertensive patients[J ]. Diabetes care, 2003, Jan 26 (1):172-8.
  • 6Subodh v. Vascular insulin resistance in fructose-hypertensive rats [J]. Europera Journal of Pharmacology. 322(1997)R1 - R2.

共引文献38

同被引文献31

  • 1杨连伟,孔俭,葛姝颖.罗格列酮对自发性高血压大鼠心脏保护作用的形态学研究[J].中国老年学杂志,2004,24(10):937-939. 被引量:6
  • 2李光伟,王金平,李春梅,陈燕燕,杨文英,邢小燕,刘克莉,唐玉龙,黎辉.胰岛素增敏剂罗格列酮抗高血压作用探讨[J].中华内科杂志,2004,43(12):907-910. 被引量:55
  • 3程歆琦,鄢盛恺,宋耀虹.代谢综合征与血脂异常[J].国外医学(临床生物化学与检验学分册),2005,26(2):77-79. 被引量:16
  • 4王萍萍,邵明柏,李杰,王新莉,常亚东.罗格列酮对兔血脂紊乱及动脉脂质沉着的影响[J].中国老年学杂志,2007,27(6):537-539. 被引量:3
  • 5He J,Klag MJ,Caballero B,et al.Plasma insulin level and incidence of hypertension in African Americans and whites[J].Arch Intern Med,1999,159(5):498-503.
  • 6Zavaroni I,Bonini L,Gasparini P,et al.Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus,hypertension,and coronary heart disease:the Barilla factory revisited[J].Metabolism,1999;48(8):989-94.
  • 7Laterza MC,de Matos LD,Trombetta IC,et al.Exercise training restores baroreflex sensitivity in never-treated hypertensive patients[J].Hypertension,2007;49(6):1298-306.
  • 8Guo Q,Minami N,Mori N,et al.Effects of antihypertensive drugs and exercise training on insulin sensitivity in spontaneously hypertensive rats[J].Hypertens Res,2008;31(13):525-33.
  • 9Asakawa M,Nagai T,Nagai T,et al.Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo[J].Circulation,2002;105(10):1240-6.
  • 10Mann JI.Can dietary intervention produce long-term reduction in insulin resistance[J] ?Br J Nutr,2000;83(1):169-72.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部